Minneapolis, MN, United States of America

Fabrizio Rinaldi


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fabrizio Rinaldi: Innovator in Stem Cell Research

Introduction

Fabrizio Rinaldi is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of stem cell research, holding 2 patents that showcase his innovative approaches to gene targeting and stem cell differentiation profiling.

Latest Patents

Rinaldi's latest patents include "Methods for non-invasive profiling of stem cell differentiation." This method involves harvesting differentiation media supernatant containing secreted analytes from key time points during stem cell differentiation. It also includes performing qualitative and quantitative analyses of the differentiation media supernatant with respect to at least one secreted analyte, identifying trends in analyte expression based on these analyses. Another significant patent is "Gene targeting methods and tools," which provides a general method for correcting genes with known mutations. This patent includes a set of tools, such as TALENs and gene targeting vectors, to facilitate the correction of genes that may vary from subject to subject.

Career Highlights

Throughout his career, Rinaldi has worked with prominent organizations, including Bio-Techne Corporation and the University of Minnesota. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Rinaldi has collaborated with notable colleagues, including Richard Karl Fuerstenberg and Joy Lynn Aho. These collaborations have further enriched his research and innovation in the field.

Conclusion

Fabrizio Rinaldi's contributions to stem cell research through his patents and collaborations highlight his role as an influential inventor. His innovative methods and tools continue to pave the way for advancements in gene targeting and stem cell differentiation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…